01:29:17 EST Sun 07 Dec 2025
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Tilray Brands Inc
Symbol TLRY
Shares Issued 661,605,734
Close 2025-11-04 C$ 1.74
Market Cap C$ 1,151,193,977
Recent Sedar Documents

Tilray Brands amends Tilray Medical pricing programs

2025-11-04 16:27 ET - News Release

Mr. Blair MacNeil reports

TILRAY MEDICAL SETS THE STANDARD FOR COMPASSIONATE PRICING, BROADENING ACCESS TO MEDICAL CANNABIS FOR PATIENTS, SENIORS, FIRST RESPONDERS, AND VETERANS THROUGH EXPANDED PRICING PROGRAMS ACROSS CANADA

Tilray Medical, a division of Tilray Brands Inc. has made significant updates to its Tilray Medical pricing programs in Canada, reinforcing its commitment to affordability, inclusivity and patient support. These changes are designed to make medical cannabis more accessible for patients nationwide while recognizing the unique needs of seniors, first responders, pediatric patients and those facing financial challenges.

As part of these updates, Tilray Medical's compassionate pricing program now features an increased annual income eligibility threshold of $65,000, up from $32,500, ensuring more patients qualify for support. To apply, patients must submit their notice of assessment for the most recent taxation year to info@tilraymedical.com. Patients enrolled in this program will continue to benefit from promotional campaigns and additional savings opportunities. Tilray Medical has also strengthened its seniors pricing program to better support elderly patients. The first responders appreciation program, front-line workers appreciation program, and pediatric pricing program continue to provide dedicated support for those who serve communities and families managing pediatric care. Additionally, Tilray Medical continues to provide specialized support through its warrior wellness program for veterans and its first responders appreciation program, ensuring personalized care and streamlined access to medical cannabis.

"At Tilray Medical, our unwavering mission is to place patients at the heart of everything we do," said Blair MacNeil, president of Tilray Canada. "With our expanded eligibility criteria and enhanced discounts across all pricing programs, we are leading the industry by setting a new standard for compassionate access. These improvements not only remove financial barriers but also reinforce our commitment to health equity, empowering more Canadians, including seniors, veterans and families, to access the medical cannabis they need with dignity and affordability. As we continue to innovate and advocate for patient-centred care, Tilray Medical proudly sets the pace for responsible leadership in the medical cannabis sector."

About Tilray Medical Inc.

Tilray Medical is dedicated to transforming lives and fostering dignity for patients in need through safe and reliable access to a global portfolio of medical cannabis brands, including Tilray Medical, Tilray Craft, Broken Coast and Redecan. Tilray Medical grew from being one of the first companies to become an approved licensed producer of medical cannabis in Canada to building the first GMP-certified (good manufacturing practice) cannabis production facilities in Portugal and Germany. Today, Tilray Medical is a leading supplier of medical cannabis with a portfolio of brands and products designed to meet the needs of the company's patients worldwide.

About Tilray Brands Inc.

Tilray Brands is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, New Zealand and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness and entertainment, elevating lives through moments of connection. Tilray's mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy and create memorable experiences. Tilray's unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods and craft beverages.

We seek Safe Harbor.

© 2025 Canjex Publishing Ltd. All rights reserved.